Vimarsana
Biggest News Aggregation in the World

Page 18 - Major Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Major Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Major Project Today - Breaking & Trending Today

Battery metals market surging on spiking demand and uncertain supply - Vimarsana News

Battery metals market surging on spiking demand and uncertain supply

Between COVID-19 and the Russian invasion of Ukraine, global commodity markets have had no room to breathe, constantly rocked by price spikes, supply...

ASCO 2022 | Ascentage Pharma to Present Data from Seven Clinical Studies at the 2022 American Society of Clinical Oncology Annual Meeting - Vimarsana News

ASCO 2022 | Ascentage Pharma to Present Data from Seven Clinical Studies at the 2022 American Society of Clinical Oncology Annual Meeting

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

AACR 2022 | Ascentage Pharma Presents Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022 - Vimarsana News

AACR 2022 | Ascentage Pharma Presents Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Dundalk IT students win double at the Royal Television Society Awards - Vimarsana News

Dundalk IT students win double at the Royal Television Society Awards

Dundalk Institute of Technology are absolutely thrilled to report two prestigious wins for their BA(Hons) Film and Television Production students at the 2022 Ro...

Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Rare Pediatric Disease Designation by the US FDA for the Treatment of Neuroblastoma - Vimarsana News

Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Rare Pediatric Disease Designation by the US FDA for the Treatment of Neuroblastoma

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...